Table I.

Patients and clinicopathologic features.

Characteristic	Patients with PCa (n=111)
Age range (years)	47–83
Median age (years)	58
Preoperative prostate-specific antigena
<4 ng/ml	17
4–10 ng/ml	68
≥10 ng/ml	24
Gleason scorea
6	35
7	55
8	8
9	9
Pathological stagea
pT2	69
pT3	30
pT4	7
Follow-up range (months)	1–128
Biochemical recurrence (n)	25
1–12 months	12
13–24 months	6
>24 months	7

^aData missing from some patients.